Symbol="ZNTL"
AssetType="Common Stock"
Name="Zentalis PharmaceuticalsÂ Llc"
Description="Zentalis Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing small molecule therapies for the treatment of various cancers. The company is headquartered in New York, New York."
CIK="1725160"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="530 SEVENTH AVENUE, SUITE 2201, NEW YORK, NY, US"
FiscalYearEnd="December"
LatestQuarter="2023-03-31"
MarketCapitalization="1850900000"
EBITDA="-232919008"
PERatio="None"
PEGRatio="None"
BookValue="6.49"
DividendPerShare="0"
DividendYield="0"
EPS="-4.22"
RevenuePerShareTTM="0"
ProfitMargin="0"
OperatingMarginTTM="0"
ReturnOnAssetsTTM="-0.327"
ReturnOnEquityTTM="-0.688"
RevenueTTM="0"
GrossProfitTTM="0"
DilutedEPSTTM="-4.22"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="0"
AnalystTargetPrice="50.3"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="-"
PriceToBookRatio="2.661"
EVToRevenue="-"
EVToEBITDA="-3.24"
Beta="1.808"
num_52WeekHigh="32.34"
num_52WeekLow="15.55"
num_50DayMovingAverage="26.85"
num_200DayMovingAverage="22.42"
SharesOutstanding="70510000"
DividendDate="None"
ExDividendDate="None"
symbol="ZNTL"
open="25.85"
high="26.15"
low="25.40"
price="26.11"
volume="433924.00"
latest_trading_day="2023-08-02"
previous_close="26.25"
change="-0.14"
change_percent="-0.5333%"
aroon_positive_momentum_days="62"
aroon_negative_momentum_days="0"
trend_strength="Absent or Weak Trend"
buying_signal="Weak Buy Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="62"
Volume_recent_avg="821063"
Change_recent_avg="0.04"
Delta_recent_avg="1.32"
Variance_recent_avg="0.66"
Change_ratio_recent_avg="0.17"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="positive"
Aroon_change="FALSE"
Aroon_momentum_positive="62"
Aroon_momentum_negative="38"
image_negative_thumbnail_id_1="1088"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0121.jpeg"
image_negative_thumbnail_id_2="159"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0017.jpeg"
image_neutral_thumbnail_id_1="541"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0058.jpeg"
image_neutral_thumbnail_id_2="573"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0026.jpeg"
image_positive_thumbnail_id_1="655"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0053.jpeg"
image_positive_thumbnail_id_2="953"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0115.jpeg"
image_professor_thumbnail_id_1="1201"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0035.jpeg"
image_professor_thumbnail_id_2="1199"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0033.jpeg"
